Professional Overview
Anthony Sampietro is a seasoned executive currently serving as Co-Founder & CEO at Ocular Science, headquartered in Manhattan Beach, California. His expertise spans the medical device industry, with a focus on ophthalmology and sales management.
Experience Summary
Current Role
As Co-Founder & CEO of Ocular Science, Anthony Sampietro oversees the strategic direction and operational management of the company. His key responsibilities include driving business growth, leading cross-functional teams, and fostering partnerships within the ophthalmic industry. Under his leadership, Ocular Science has established itself as a notable player in the development of ophthalmic technologies and solutions.
Career Progression
Anthony Sampietro's career progression showcases a steady growth trajectory, with notable previous roles including Western Regional Sales Director at OptiMedica, and various positions at Alcon Laboratories, Inc., such as Director of North China Phaco Development, Business Development Manager, and Vitreoretinal Account Manager. He began his career as a Sales Rep at Ethicon, Inc. Each role has contributed to his expertise in sales management, business development, and leadership within the medical device industry.
Areas of Expertise
Anthony Sampietro's areas of expertise include:
- Industry-specific skills: Ophthalmology, medical devices, and sales strategy.
- Technical competencies: Phaco development, vitreoretinal surgery, and ocular science.
- Leadership and management capabilities: Team leadership, business development, and operational management.
Professional Impact
Throughout his career, Anthony Sampietro has contributed to the growth and development of the ophthalmic industry through his work at Ocular Science and previous roles. His ability to drive business expansion, lead innovative projects, and build strategic partnerships has had a significant impact on the industry.
Conclusion
Anthony Sampietro's professional trajectory is marked by continuous growth, leadership, and innovation within the ophthalmic industry. Currently, as Co-Founder & CEO of Ocular Science, he continues to focus on advancing ophthalmic technologies and solutions. His value proposition lies in his unique blend of industry expertise, technical knowledge, and leadership capabilities, making him a pivotal figure in the medical device sector.
